100 related articles for article (PubMed ID: 6609500)
1. Cephalosporin resistance in strains of Klebsiella oxytoca isolated during antibiotic therapy.
Then RL; Glauser MP; Angehrn P; Arisawa M
Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1983 Jul; 254(4):469-79. PubMed ID: 6609500
[TBL] [Abstract][Full Text] [Related]
2. [Prevalence of extended-spectrum beta-lactamases in nosocomial Escherichia coli and Klebsiella spp. strains isolated from blood cultures].
Zarakolu P; Metan G; Hasçelik G; Akova M
Mikrobiyol Bul; 2007 Oct; 41(4):579-84. PubMed ID: 18173077
[TBL] [Abstract][Full Text] [Related]
3. [Antibiotic resistance rates of extended spectrum beta-lactamase producing Escherichia coli and Klebsiella spp. strains isolated from urinary tract infections in a private hospital].
Akyar I
Mikrobiyol Bul; 2008 Oct; 42(4):713-5. PubMed ID: 19149097
[TBL] [Abstract][Full Text] [Related]
4. Outbreak of neonatal Klebsiella septicaemia: a review of antimicrobial sensitivities.
Akindele JA; Rotilu IO
Afr J Med Med Sci; 1997; 26(1-2):51-3. PubMed ID: 10895230
[TBL] [Abstract][Full Text] [Related]
5. Retrospective analysis of clinical and microbiological aspects of Klebsiella oxytoca bacteremia over a 10-year period.
Kim BN; Ryu J; Kim YS; Woo JH
Eur J Clin Microbiol Infect Dis; 2002 Jun; 21(6):419-26. PubMed ID: 12111596
[TBL] [Abstract][Full Text] [Related]
6. Prevalent phenotypes and antibiotic resistance in Escherichia coli and Klebsiella pneumoniae at an Indian tertiary care hospital: plasmid-mediated cefoxitin resistance.
Shahid M; Malik A; Akram M; Agrawal LM; Khan AU; Agrawal M
Int J Infect Dis; 2008 May; 12(3):256-64. PubMed ID: 17981482
[TBL] [Abstract][Full Text] [Related]
7. In vivo selection of OmpK35-deficient mutant after cefuroxime therapy for primary liver abscess caused by Klebsiella pneumoniae.
Lee CH; Chia JH; Chu C; Wu TL; Liu JW; Su LH
J Antimicrob Chemother; 2006 Oct; 58(4):857-60. PubMed ID: 16880175
[TBL] [Abstract][Full Text] [Related]
8. [Resistance to cephalosporin in hospital strains of the KES group].
Granatiero F; Grandis C; Malandrino M; Oneglio R
G Batteriol Virol Immunol; 1989; 82(1-12):141-51. PubMed ID: 2490396
[TBL] [Abstract][Full Text] [Related]
9. Beta-lactam susceptibilities and prevalence of ESBL-producing isolates among more than 5000 European Enterobacteriaceae isolates.
Nijssen S; Florijn A; Bonten MJ; Schmitz FJ; Verhoef J; Fluit AC
Int J Antimicrob Agents; 2004 Dec; 24(6):585-91. PubMed ID: 15555882
[TBL] [Abstract][Full Text] [Related]
10. [Investigation of the frequency of extended spectrum beta-lactamases and antibiotic resistance in clinical isolates of Escherichia coli and Klebsiella sp].
Ekşi F; Ozer G; Balci I
Mikrobiyol Bul; 2007 Jul; 41(3):447-52. PubMed ID: 17933257
[TBL] [Abstract][Full Text] [Related]
11. Occurrence of extended spectrum beta-lactamase enzymes in clinical isolates of Klebsiella species from Harar region, eastern Ethiopia.
Seid J; Asrat D
Acta Trop; 2005 Aug; 95(2):143-8. PubMed ID: 15993831
[TBL] [Abstract][Full Text] [Related]
12. Phenotypic confirmation of extended-spectrum B-lactamases (ESBL) in clinical isolates of Escherichia coli and Klebsiella pneumoniae at the San Juan Veterans Affairs Medical Center.
Del Carmen Rodríguez M; Vera DE; Ramírez-Ronda CH; Saavedra S
P R Health Sci J; 2004 Sep; 23(3):207-15. PubMed ID: 15631176
[TBL] [Abstract][Full Text] [Related]
13. [Comparison of four recently introduced cephalosporins with respect to probability of resistance in multiresistant strains of Escherichia coli, Proteus mirabilis and Klebsiella spec. (author's transl)].
Loch R; Schröter G
Zentralbl Bakteriol Orig A; 1979; 245(3):312-6. PubMed ID: 44785
[TBL] [Abstract][Full Text] [Related]
14. Neonatal intensive care unit outbreak caused by a strain of Klebsiella oxytoca resistant to aztreonam due to overproduction of chromosomal beta-lactamase.
Jeong SH; Kim WM; Chang CL; Kim JM; Lee K; Chong Y; Hwang HY; Baek YW; Chung HK; Woo IG; Ku JY
J Hosp Infect; 2001 Aug; 48(4):281-8. PubMed ID: 11461129
[TBL] [Abstract][Full Text] [Related]
15. Antimicrobial susceptibility pattern and prevalence of extended spectrum beta-lactamase (ESBLs) producing strains of Klebsiella pneumoniae from a major hospital in New Delhi.
Grover SS; Sharma M; Pasha ST; Singh G; Lal S
J Commun Dis; 2004 Mar; 36(1):17-26. PubMed ID: 16295682
[TBL] [Abstract][Full Text] [Related]
16. [Mechanisms of resistance in Enterobacteriaceae towards beta-lactamase antibiotics].
Susić E
Acta Med Croatica; 2004; 58(4):307-12. PubMed ID: 15700687
[TBL] [Abstract][Full Text] [Related]
17. Analysis of plasmid-mediated multidrug resistance in Escherichia coli and Klebsiella oxytoca isolates from clinical specimens in Japan.
Ode T; Saito R; Kumita W; Sato K; Okugawa S; Moriya K; Koike K; Okamura N
Int J Antimicrob Agents; 2009 Oct; 34(4):347-50. PubMed ID: 19560903
[TBL] [Abstract][Full Text] [Related]
18. Comparisons of parenteral broad-spectrum cephalosporins tested against bacterial isolates from pediatric patients: report from the SENTRY Antimicrobial Surveillance Program (1998-2004).
Jones RN; Sader HS; Fritsche TR; Pottumarthy S
Diagn Microbiol Infect Dis; 2007 Jan; 57(1):109-16. PubMed ID: 16930923
[TBL] [Abstract][Full Text] [Related]
19. Extended spectrum b lactamases (ESBL) in clinical isolates of Klebsiella pneumoniae and Escherichia coli.
Duttaroy B; Mehta S
Indian J Pathol Microbiol; 2005 Jan; 48(1):45-8. PubMed ID: 16758790
[TBL] [Abstract][Full Text] [Related]
20. Clinical implications of extended spectrum beta-lactamase (ESBL) producing Klebsiella species and Escherichia coli on cefepime effectiveness.
Kotapati S; Kuti JL; Nightingale CH; Nicolau DP
J Infect; 2005 Oct; 51(3):211-7. PubMed ID: 16230218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
